A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation

Charles K. Kaufman(Howard Hughes Medical Institute), Christian Mosimann(University of Zurich), Zi Peng Fan(Whitehead Institute for Biomedical Research), Song Yang(Howard Hughes Medical Institute), Andrew Thomas(Howard Hughes Medical Institute), Julien Ablain(Howard Hughes Medical Institute), Justin L. Tan(Howard Hughes Medical Institute), Rachel Fogley(Howard Hughes Medical Institute), Ellen van Rooijen(Howard Hughes Medical Institute), Elliott J. Hagedorn(Howard Hughes Medical Institute), Christie Ciarlo(Howard Hughes Medical Institute), Richard M. White(Memorial Sloan Kettering Cancer Center), Dominick A. Matos(Harvard University), Ann‐Christin Puller(Universität Hamburg), Cristina Santoriello(Howard Hughes Medical Institute), Eric C. Liao(Harvard University), Richard A. Young(Whitehead Institute for Biomedical Research), Leonard I. Zon(Howard Hughes Medical Institute)
Science
January 28, 2016
Cited by 426Open Access

Abstract

The "cancerized field" concept posits that cancer-prone cells in a given tissue share an oncogenic mutation, but only discreet clones within the field initiate tumors. Most benign nevi carry oncogenic BRAF(V600E) mutations but rarely become melanoma. The zebrafish crestin gene is expressed embryonically in neural crest progenitors (NCPs) and specifically reexpressed in melanoma. Live imaging of transgenic zebrafish crestin reporters shows that within a cancerized field (BRAF(V600E)-mutant; p53-deficient), a single melanocyte reactivates the NCP state, revealing a fate change at melanoma initiation in this model. NCP transcription factors, including sox10, regulate crestin expression. Forced sox10 overexpression in melanocytes accelerated melanoma formation, which is consistent with activation of NCP genes and super-enhancers leading to melanoma. Our work highlights NCP state reemergence as a key event in melanoma initiation.


Related Papers